Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127430-15-000083
Filing Date
2015-12-15
Accepted
2015-12-15 16:07:52
Documents
1
Period of Report
2015-12-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5497
  Complete submission text file 0001127430-15-000083.txt   6969
Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Issuer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENENTECH INC 1 DNA WAY MS 49 SOUTH SAN FRANCISCO CA 94080-4990
Business Address
POTTER MYRTLE S (Reporting) CIK: 0001214130 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30739 | Film No.: 151288603